Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	NextCure	Immunic	Axon Enterprise	Trevena	Aeglea BioTherapeutics
Symbol	NASDAQ:NXTC	NASDAQ:IMUX	NASDAQ:AXON	NASDAQ:TRVN	NASDAQ:AGLE
Price Information
Current Price	$11.36	$15.95	$165.49	$2.15	$7.45
52 Week Range	Hold	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	1.6	1.5	1.3	1.4	1.7
Analysis Score	3.1	3.5	3.4	3.5	3.5
Community Score	2.6	2.7	2.4	3.3	2.7
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.8	0.0	0.0	1.7
Earnings & Valuation Score	0.6	0.6	0.6	0.0	0.6
Analyst Ratings
Consensus Recommendation	Hold	Buy	Buy	Buy	Buy
Consensus Price Target	$23.33	$58.86	$183.50	$5.00	$12.67
% Upside from Price Target	105.40% upside	269.01% upside	10.88% upside	133.10% upside	70.02% upside
Trade Information
Market Cap	$313.00 million	$330.45 million	$10.52 billion	$336.83 million	$357.13 million
Beta	-0.4	2.21	1.21	2.59	1.66
Average Volume	263,810	271,981	744,748	3,737,088	230,385
Sales & Book Value
Annual Revenue	$6.35 million	N/A	N/A	$30,000.00	$3.89 million
Price / Sales	49.29	N/A	N/A	11,227.65	91.81
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$14.13 per share	$5.77 per share	$0.19 per share	$0.32 per share	$2.07 per share
Price / Book	0.80	N/A	N/A	6.70	3.60
Profitability
Net Income	$-33,740,000.00	$-34,930,000.00	$-221,570,000.00	$-24,870,000.00	$-78,250,000.00
EPS	($2.15)	($4.52)	($2.06)	($0.27)	($2.45)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	-10.00%	-46.33%	-416.05%	-42.49%	-81.42%
Return on Assets (ROA)	-9.51%	-42.50%	-124.55%	-34.83%	-66.88%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.01%	N/A	1.24%	N/A	N/A
Current Ratio	51.73%	17.13%	2.02%	28.08%	10.06%
Quick Ratio	51.73%	17.13%	2.02%	28.08%	10.06%
Ownership Information
Institutional Ownership Percentage	66.30%	41.26%	7.58%	11.62%	80.87%
Insider Ownership Percentage	9.05%	12.07%	6.00%	5.20%	13.70%
Miscellaneous
Employees	69	26	1,323	24	87
Shares Outstanding	27.55 million	20.72 million	63.55 million	157.03 million	47.94 million
Next Earnings Date	3/11/2021 (Estimated)	5/14/2021 (Estimated)	5/6/2021 (Estimated)	3/11/2021 (Estimated)	3/1/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources